dimethyl sulfoxide has been researched along with Hodgkin Disease in 9 studies
Dimethyl Sulfoxide: A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation.
dimethyl sulfoxide : A 2-carbon sulfoxide in which the sulfur atom has two methyl substituents.
Hodgkin Disease: A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Products cryopreserved with dimethyl sulfoxide (DMSO) in stem cell transplant (SCT) often cause many adverse effects during their infusion (major cardiovascular events, dyspnea … even death)." | 2.77 | An automatic wash method for dimethyl sulfoxide removal in autologous hematopoietic stem cell transplantation decreases the adverse effects related to infusion. ( Blanquer, M; Cabañas-Perianes, V; García-Hernández, A; Gómez-Espuch, J; Insausti, CL; Majado, MJ; Menchón, P; Monserrat, J; Moraleda, JM; Morales, A; Sánchez-Ibáñez, MV; Sánchez-Salinas, A, 2012) |
| "The other patient who was a victim of Hodgkin's disease, stage IV, and was transplanted in 3rd remission, expired on the 59th day because of the complication of idiopathic interstitial pneumonitis despite excellent granulocytopoietic reconstitution." | 1.27 | Bone marrow cryopreservation and clinical implications in autologous bone marrow transplantation. ( Chen, KY; Chen, PM; Chuang, MW; Hsieh, RK; Liu, JH; Tzeng, CH; Wang, SY; Yung, CH, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gharbaran, R | 1 |
| Zhang, B | 1 |
| Valerio, L | 1 |
| Onwumere, O | 1 |
| Wong, M | 1 |
| Mighty, J | 1 |
| Redenti, S | 1 |
| Atas, E | 1 |
| Kesik, V | 1 |
| Sari, E | 1 |
| Kismet, E | 1 |
| Yaris, N | 1 |
| Koseoglu, V | 1 |
| Sánchez-Salinas, A | 1 |
| Cabañas-Perianes, V | 1 |
| Blanquer, M | 1 |
| Majado, MJ | 1 |
| Insausti, CL | 1 |
| Monserrat, J | 1 |
| Sánchez-Ibáñez, MV | 1 |
| Menchón, P | 1 |
| García-Hernández, A | 1 |
| Gómez-Espuch, J | 1 |
| Morales, A | 1 |
| Moraleda, JM | 1 |
| Niller, HH | 1 |
| Salamon, D | 1 |
| Ilg, K | 1 |
| Koroknai, A | 1 |
| Banati, F | 1 |
| Bauml, G | 1 |
| Rucker, O | 1 |
| Schwarzmann, F | 1 |
| Wolf, H | 1 |
| Minarovits, J | 1 |
| Bakken, AM | 1 |
| Bruserud, O | 1 |
| Abrahamsen, JF | 1 |
| Otrock, ZK | 1 |
| Beydoun, A | 1 |
| Barada, WM | 1 |
| Masroujeh, R | 1 |
| Hourani, R | 1 |
| Bazarbachi, A | 1 |
| Tzeng, CH | 1 |
| Hsieh, RK | 1 |
| Chuang, MW | 1 |
| Liu, JH | 1 |
| Chen, KY | 1 |
| Yung, CH | 1 |
| Wang, SY | 1 |
| Chen, PM | 1 |
| Garbrecht, M | 1 |
| Mertelsmann, R | 1 |
| Heller-Schöch, G | 1 |
| Schöch, G | 1 |
| Seibert, FB | 1 |
| Farrelly, FK | 1 |
| Shepherd, CC | 1 |
1 trial available for dimethyl sulfoxide and Hodgkin Disease
| Article | Year |
|---|---|
An automatic wash method for dimethyl sulfoxide removal in autologous hematopoietic stem cell transplantation decreases the adverse effects related to infusion.
Topics: Adult; Aged; Blood Component Removal; Blood Preservation; Blood Transfusion, Autologous; Cell Surviv | 2012 |
8 other studies available for dimethyl sulfoxide and Hodgkin Disease
| Article | Year |
|---|---|
Effects of vitamin D3 and its chemical analogs on the growth of Hodgkin's lymphoma, in vitro.
Topics: Calcitriol; Cell Line, Tumor; Cell Proliferation; Cholecalciferol; Dimethyl Sulfoxide; Gene Expressi | 2019 |
Temporary vision loss because of dimethyl sulfoxide in autologous stem cell transplantation.
Topics: Adolescent; Biopsy; Cell Survival; Cryopreservation; Dimethyl Sulfoxide; Female; Hematopoietic Stem | 2012 |
The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis.
Topics: Binding Sites; Cell Line, Transformed; Chromatin; Dimethyl Sulfoxide; Genes, myc; Herpesvirus 4, Hum | 2003 |
No differences in colony formation of peripheral blood stem cells frozen with 5% or 10% dimethyl sulfoxide.
Topics: Bone Neoplasms; Cell Division; Colony-Forming Units Assay; Cryoprotective Agents; Dimethyl Sulfoxide | 2003 |
Transient global amnesia associated with the infusion of DMSO-cryopreserved autologous peripheral blood stem cells.
Topics: Adult; Alkalosis, Respiratory; Amnesia, Retrograde; Amnesia, Transient Global; Antineoplastic Combin | 2008 |
Bone marrow cryopreservation and clinical implications in autologous bone marrow transplantation.
Topics: Adult; Bone Marrow Cells; Bone Marrow Transplantation; Cell Separation; Colony-Forming Units Assay; | 1988 |
DNA-dependent DNA and RNA polymerases and tRNA-methyl-transferases in human leukemia and differentiating Friend virus leukemia cells.
Topics: Animals; Cations, Divalent; Cell Differentiation; Cell Nucleus; Cell Separation; Chemical Phenomena; | 1974 |
DMSO and other combatants against bacteria isolated from leukemia and cancer patients.
Topics: Antitubercular Agents; Bacteria; Bacteriological Techniques; Blood Cells; Culture Media; Dimethyl Su | 1967 |